{"title":"A Mitochondrial Autophagy-Synthesis Dynamic Equilibrium Liposome for the Repair of Energy Metabolism in Acute Kidney Injury.","authors":"Mengdie Yu, Zhangwei Yan, Jiamei Zhao, Lvjing Wang, Xuelian Yang, Xinhai Liao, Wenying Yu, Xiaozhou Mou, Yu Cai","doi":"10.1002/adhm.71904","DOIUrl":"https://doi.org/10.1002/adhm.71904","url":null,"abstract":"<p><p>Acute kidney injury (AKI) is a clinical syndrome primarily attributed to mitochondrial dysfunction, characterized by disrupted mitochondrial balance. Impaired biogenesis leads to insufficient energy supply, while defective autophagy results in the accumulation of damaged mitochondria-both of which exacerbate injury to renal tubular epithelial cells. In this study, we developed melatonin/pioglitazone liposomes (MP@Lip) for AKI therapy via restoration of mitochondrial dynamic balance. When melatonin and pioglitazone was jointly delivered to damaged renal tubules, they activated mitochondrial autophagy and biogenesis, thereby bidirectionally restoring mitochondrial network homeostasis. Mechanistically, AMPK/SIRT3/PGC-1α-related signaling may be involved in the mitochondrial protection of MP@Lip. Upon AMPK phosphorylation, SIRT1/SIRT3 deacetylase activity is upregulated, the ratio of LC3B-II/LC3B-I increases, p62/SQSTM1 decreases, and autophagy is enhanced. PGC-1α enhances transcriptional activity and promotes the expression of mitochondrial biogenic markers (TOM20). This complementary degradation-synthesis loop gradually restores mitochondrial dynamic balance. In vitro experiments confirmed that MP@Lip reduces ROS production and apoptosis while restoring mitochondrial membrane potential. In vivo studies demonstrated improvement in renal function indicators, alleviation of inflammatory responses and histopathological damage, and no systemic toxicity. This strategy shifts AKI treatment from symptomatic support to ameliorating mitochondrial dysfunction, providing a targeted, complementary and relatively safe approach that may be applicable to other mitochondrial functional-related diseases.</p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149339906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ziqun Chen, Zhibin Guo, Haotian Du, Tingting Liu, Qi Shi, Yahui Yang, Jiang Wu, Yi Liu, Yujiao Liu
{"title":"Inhibiting Lactylation-Mediated Metabolic-Epigenetic Reprogramming to Potentiate Tumor Photo-Immunotherapy.","authors":"Ziqun Chen, Zhibin Guo, Haotian Du, Tingting Liu, Qi Shi, Yahui Yang, Jiang Wu, Yi Liu, Yujiao Liu","doi":"10.1002/adhm.71955","DOIUrl":"https://doi.org/10.1002/adhm.71955","url":null,"abstract":"<p><p>Cancer immunotherapies face limitations in treating \"cold\" tumors due to immune suppression driven by metabolic dysregulation within the tumor microenvironment. Research has revealed that tumor cells produce excess lactate via hypoxia-induced glycolysis, promoting histone lactylation and establishing immunosuppression-associated metabolic-epigenetic reprogramming. Here, a near-infrared (NIR)-triggered nanoplatform (RgA-L-I/P/R) has been developed to fundamentally dismantle the immunosuppression via the metabolic-epigenetic axis. Upon NIR excitation, the platform released oxygen from perfluoropentane (PFP) (\"oxygen unlocking chamber\") in the tumor through dual targeting of AS1411 and Rg3 (\"nano-warhead\"), liberating the IR-1048 and the CRISPR/Cas9 ribonucleoprotein (RNP) (\"NIR immune trigger\" and \"metabolic nanolock\"). IR-1048 induced immunogenic cell death (ICD) to trigger dendritic cell maturation and cytotoxic T lymphocyte infiltration, while CRISPR/Cas9 RNP induced LDHA (lactate dehydrogenase A) gene knockdown that locked the lactate supply and reprogrammed metabolism and epigenetics. These changes reduced histone lactylation and IL-10 expression, promoting the conversion of tumor-associated macrophages to the M1 type and synergistically downregulating hypoxia-inducible factor-1α (HIF-1α) and programmed death-ligand 1 (PD-L1) expression upon oxygen release. This nanoplatform enables synergistic photothermal immunostimulation with CRISPR-mediated metabolic and epigenetic reprogramming. Rather than merely countering mild downstream immune regulation by ICD, it seeks to fundamentally eliminate the immunosuppression, offering novel therapeutic strategies through the metabolic-epigenetic pathway for poorly immunoresponsive tumors.</p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149339908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Junyu Liu, Xiaobin Li, Xupu Xing, Yun Chen, Yiting Li, Chang Wen, Haihong Chen, Yumao He, Yilin Zheng, Jin Xie, Xiao Dong Chen, Yi Wang, Chong Zhang, Xin-Hui Xing, Can Yang Zhang
{"title":"Programmed Gut-Liver-Targeted Oral Delivery of Peptide-Probiotic Nano-Microsystem for Metabolic Complications of Hyperglycemia and Hyperuricemia.","authors":"Junyu Liu, Xiaobin Li, Xupu Xing, Yun Chen, Yiting Li, Chang Wen, Haihong Chen, Yumao He, Yilin Zheng, Jin Xie, Xiao Dong Chen, Yi Wang, Chong Zhang, Xin-Hui Xing, Can Yang Zhang","doi":"10.1002/adhm.71954","DOIUrl":"https://doi.org/10.1002/adhm.71954","url":null,"abstract":"<p><p>Hyperglycemia and hyperuricemia are highly prevalent metabolic comorbidities characterized by systemic metabolic disturbances and complex multi-organ pathogenesis, urgently requiring synergistic multi-organ-targeted therapeutic strategies. Here, we present a programmed gut-liver-targeted oral peptide-probiotic nano-microsystem for metabolic complications of hyperglycemia and hyperuricemia treatment. The xanthine oxidase (XOD)-inhibitory peptide PPKNW (P1) was loaded in a layer-by-layer reactive oxygen species (ROS)-responsive nanoparticle (P1NPs), followed by engineering on the surface of probiotic Akkermansia muciniphila (Akk), resulting in a peptide-probiotic nano-microsystem (P1NPs@Akk). After oral administration, P1NPs@Akk remained stable during gastric passage. Upon reaching intestinal environment, CS and HA layers were progressively removed, exposing the P1-loaded polymersomes, which were transported across the intestinal epithelium via PAT-1-mediated transcytosis. In the liver, P1 was released in response to ROS-mediated disulfide bond cleavage to inhibit XOD and reduce uric acid synthesis. Meanwhile, Akk was delivered to and colonized in the intestine to regulate glucose metabolism. In a mouse model of combined hyperglycemia and hyperuricemia, P1NPs@Akk promoted hepatic accumulation of P1 and intestinal enrichment of Akk, resulting in significant reductions in blood glucose and uric acid levels. This work presents a programmed gut-liver-targeted oral platform that integrates peptide therapy and probiotic intervention for multi-organ regulation of metabolic disorders.</p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149331754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"NIR-Activated Ag<sub>2</sub>S Quantum Dots for Synergistic Immunomodulation and Precision Therapy of Refractory Osteomyelitis.","authors":"Rui Yao, Peiqing Sun, Ying Liu, Wusimanjiang Hailipitimu, Yaxin Chen, Zhijie Lei, Li Wang, Jianglin Yu, Wei Wei, Jing Zhao, Xusheng Qiu","doi":"10.1002/adhm.71953","DOIUrl":"https://doi.org/10.1002/adhm.71953","url":null,"abstract":"<p><p>Staphylococcus aureus (S. aureus) is a predominant clinical pathogen responsible for a wide range of infections. By forming biofilms during infection, S. aureus evades conventional therapies, leading to persistent infections and treatment failure. To address this challenge, we employed silver sulfide quantum dots (Ag<sub>2</sub>S QDs) for near-infrared (NIR) phototherapy. In vitro, the nanoagent achieved >99.99% killing of S. aureus within 10 minutes and reduced biofilm biomass by >58%. In a murine osteomyelitis model, a single NIR treatment reduced bacterial loads by 71.83% on implants and 59.18% in bone tissue, while also suppressing key inflammatory cytokines, with local macrophage polarization shifting from an M1-dominant to an M2-dominant phenotype. Histopathological and micro-CT analyses indicated attenuated bone destruction. The nanoagent showed favorable biosafety, with no systemic toxicity in major organs and osteoblast viability >75% at therapeutic concentrations. Together, these results demonstrate a phototherapeutic strategy with combined antibacterial and anti-biofilm effects, supporting its potential as an adjuvant approach for managing refractory osteomyelitis.</p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149331753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hypoxia-Guided Magnetic Catheter for Localization and Minimally Invasive Intervention in Early-Stage Lung Cancer.","authors":"Jiatian Chen, Yaxuan Jiao, Lei Li, Shengchang Zhang, Xianbing Zeng, Juncai Song, Yujing Li, Guanghao Wu, Yubing Guo","doi":"10.1002/adhm.71939","DOIUrl":"https://doi.org/10.1002/adhm.71939","url":null,"abstract":"<p><p>To enable the precise localization and minimally invasive treatment of early-stage pulmonary lesions, we developed a magnetic catheter system integrating magnetic navigation, hypoxia fluorescence imaging, and multifunctional minimally invasive intervention. The distal end of the system incorporates multiple permanent magnets, a miniature camera equipped with an optical filter, multiple fiber-optic channels, and a flexibly switchable multifunctional working channel. Under a 40 mT magnetic field applied perpendicular to the initial catheter axis, the catheter incorporating 2.0 mm-diameter magnets achieved a bending angle of 39.63° ± 2.47° and successfully navigated to multiple designated branches in the bronchial phantom. A proof-of-concept model was established using A549 lung cancer spheroids labeled with hypoxia-responsive fluorescent probes, enabling fluorescence-guided localization of simulated hypoxic lesions. In the bronchial phantom, the system successfully identified simulated hypoxic lesions and subsequently performed biopsy sampling, simulated drug delivery, and localized laser irradiation. The system was further evaluated in porcine lungs to demonstrate its navigation and localized intervention capabilities. This magnetic catheter system provides a new technological strategy for the precise localization and in situ treatment of early-stage lung cancer.</p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149316239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Core-Shell Microneedles for Sequential Delivery of Antibacterial, Antioxidant, and Anti-Inflammatory Agents in Infected Wound Healing.","authors":"Yuanyuan Liu, Qiling Jin, Yangfei Shen, Yanqun Wu, Wenwen Lei, Qiqi Luo, Wenying Zhong, Keming Xu","doi":"10.1002/adhm.71942","DOIUrl":"https://doi.org/10.1002/adhm.71942","url":null,"abstract":"<p><p>Infected wounds are dynamic pathological processes that progress through acute, chronic, and repair phases, each with distinct therapeutic requirements. Conventional treatments, which release all drugs simultaneously, often fail to meet these stage-specific needs. In this study, we develop a multifunctional core-shell microneedle (MN) system capable of sequential delivery of different therapeutics to address the requirements of various healing stages. During the acute phase, the shell composed of gelatin-hydroxyphenylalanine (Gtn-HPA) hydrogel rapidly releases bacitracin (Bac), thereby inhibiting bacterial proliferation. During the chronic phase, MMP9-responsive peptide nanoparticles (INM-1@EDA) within the MN core undergo enzymatic cleavage, releasing the edaravone (EDA) and indomethacin (INM) moieties to exert antioxidant and anti-inflammatory activities, respectively. During the repair phase, the residual gelatin at the site supports keratinocyte proliferation and migration, promoting skin tissue regeneration. In a mouse wound model with Staphylococcus aureus infection, core-shell MN treatment achieves nearly complete wound closure in 12 days (96.7 ± 1.3%) with markedly reduced bacterial burden and decreased inflammatory cytokine levels. This MN system achieves sequential release of antibacterial, anti-inflammatory, and antioxidant therapeutics based on wound microenvironments, offering new strategies for efficacious treatment of infected wounds.</p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149316238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zhidan Tan, Jin Qian, Guiquan Zhang, Jielong Zhou, Yunhui Zhang, Junhua Nie, Chenyang Wan, Man Shu, Mei Li, Anjun Qin, Shuilin Wu, Yu Zhang
{"title":"Microwave-Responsive AIE Nanocomposite Induces Immunogenic Senescence for Imaging-Guided Therapy and Bone Repair in Osteosarcoma.","authors":"Zhidan Tan, Jin Qian, Guiquan Zhang, Jielong Zhou, Yunhui Zhang, Junhua Nie, Chenyang Wan, Man Shu, Mei Li, Anjun Qin, Shuilin Wu, Yu Zhang","doi":"10.1002/adhm.71934","DOIUrl":"https://doi.org/10.1002/adhm.71934","url":null,"abstract":"<p><p>Osteosarcoma remains challenging due to incomplete tumor resection, local recurrence, and limited immunostimulatory efficacy of current microwave (MW)-based therapies. Here, we develop a multifunctional theranostic nanoplatform, GPC3@TTBC, by conjugating an osteosarcoma-targeting anti-GPC3 peptide onto aggregation-induced emission (AIE) nanoparticles. GPC3@TTBC enables selective tumor accumulation and high-contrast near-infrared fluorescence imaging, allowing precise tumor margin delineation and superior tumor-to-background resolution compared with clinically used dyes, including effective visualization in patient-derived xenograft models. Upon MW irradiation, lysosome-localized GPC3@TTBC generates robust nonthermal reactive oxygen species (ROS) through enhanced charge separation and electron transfer, resulting in substantial tumor cell apoptosis while simultaneously inducing a prominent immunogenic senescence-associated phenotype and senescence-associated secretory phenotype (SASP) response. Importantly, MW + GPC3@TTBC suppressed tumor cell migration and invasion in vitro and reduced pulmonary metastatic lesions in vivo. Meanwhile, the SASP promoted dendritic cell maturation and cytotoxic T lymphocyte activation, thereby enhancing antitumor immune responses and remodeling the tumor immune microenvironment. Beyond tumor eradication, GPC3@TTBC facilitates osteogenic microenvironment reconstruction and bone regeneration after tumor clearance, while exhibiting favorable biosafety. Collectively, GPC3@TTBC integrates targeted fluorescence-guided imaging, MW-enhanced ROS generation, immunogenic senescence induction, and bone regeneration, providing a comprehensive theranostic strategy for precise osteosarcoma treatment.</p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149316241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sunu Hangma Subba, Kaustuv Roy, Ee Hyun Kim, Yo Bin Hong, Eun-Jung Jin, Akhmad Irhas Robby, Sung Young Park
{"title":"Osteoarthritis-Microenvironment-Triggered Phase Alteration of Injectable Conductive Hydrogel for Attenuating Cartilage Degradation.","authors":"Sunu Hangma Subba, Kaustuv Roy, Ee Hyun Kim, Yo Bin Hong, Eun-Jung Jin, Akhmad Irhas Robby, Sung Young Park","doi":"10.1002/adhm.71943","DOIUrl":"https://doi.org/10.1002/adhm.71943","url":null,"abstract":"<p><p>Osteoarthritis (OA) is associated with excessive reactive oxygen species (ROS) production, which contributes substantially to chondrocyte dysfunction, oxidative stress, and cartilage degradation. Although stimuli-responsive hydrogels have emerged as promising platforms for OA therapy, conventional hydrogel-based systems exhibit limited sensitivity and require external detection equipment, highlighting the need for a simple, sensitive, and directly observable monitoring system. To address these challenges, we developed a ROS-triggered, in situ-forming gel-sol transition of a polydopamine (PDA)-loaded, diselenide-crosslinked polymer dot (PD) injectable hydrogel (HGC-PDA@PD or OA gel) as a monitorable theranostic for OA therapy at physiological temperature (37°C). The monitorable OA microenvironment-responsive hydrogel relied on interactions between the high ROS levels in OA cartilage and the OA gel, which triggered diselenide bond cleavage and the release of PDA from PD, causing a unique gel-sol transition of the OA gel. Owing to PDA release after diselenide breakage, the fluorescence and electroconductivity of the OA gel changed, which could serve as additional signals during OA detection. In vitro studies demonstrated the sensitive gel-sol transition of OA gel towards OA-induced immature articular chondrocytes (IL-1β/siSOD1/siCatalase-transfected iMACs). Furthermore, the OA gel showed a distinct gel-sol transition in cartilage of an in vivo OA mouse model compared with that in control mice. The lower transcription levels of cartilage matrix-degrading enzymes (ADAMTS4, ADAMTS5, MMP-3, and MMP-13) observed after OA gel injection confirmed that the OA gel could scavenge ROS and attenuate cartilage damage, revealing its potential application for dual-function OA diagnosis and rehabilitation.</p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149316243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Li Chen, Ningbo Liu, Changsheng Wang, Chang Cai, Shuqin Li, Yingchi Yang, Pu Wang, Xiu-Hong Wang
{"title":"Breaking the Vicious Cycle for Diabetic Wound Healing: A Dynamic-Static Dual-Mode Nanofiber Platform for NETs Degradation, Inflammation Resolution, and Scar Prevention.","authors":"Li Chen, Ningbo Liu, Changsheng Wang, Chang Cai, Shuqin Li, Yingchi Yang, Pu Wang, Xiu-Hong Wang","doi":"10.1002/adhm.71947","DOIUrl":"https://doi.org/10.1002/adhm.71947","url":null,"abstract":"<p><p>Chronic diabetic wounds are trapped in a self-perpetuating vicious cycle-persistent infection, oxidative stress, and NET-driven inflammation-that severely impairs healing. Here, we engineer a piezoelectric nanofiber membrane (DMTP) that breaks this cycle via a dynamic-static dual-mode strategy. DMTP integrates a Mn-Ti bimetallic MOF with sustained DNase I release, enabling four coordinated functions: (i) piezodynamic ROS generation for on-demand antibacterial action; (ii) an electric field to guide fibroblast migration; (iii) sustained DNase I release to degrade pathological NETs; and (iv) intrinsic POD/SOD enzyme-mimetic activity for continuous ROS scavenging. Mechanistically, we show that NETs drive fibroblast differentiation into α-SMA<sup>+</sup> myofibroblasts, a key fibrotic driver, and DMTP effectively suppresses this pro-fibrotic process. In diabetic mice, DMTP achieves 94.32% wound closure with orderly collagen deposition and modulated inflammation (TNF-α↓, TGF-β↑). In a rabbit ear hypertrophic scar model, DMTP significantly reduces scar formation by inhibiting α-SMA expression. This work offers a transformative strategy to achieve diabetic wound healing with diminished scarring by directly dismantling the infection-oxidative stress-NETs-fibrosis axis.</p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":" ","pages":""},"PeriodicalIF":11.0,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149316264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}